Issue navigation
Volume 29, Issue 5, May 2023
Leading Off
Hospitalization Experiences and Post-traumatic Stress in Inflammatory Bowel Disease: Opportunities for Change
Tiffany H Taft and others
Inflammatory Bowel Diseases, Volume 29, Issue 5, May 2023, Pages 675–683, https://doi.org/10.1093/ibd/izac148
Sustained Diet-Induced Remission in Pediatric Crohn’s Disease Is Associated With Kynurenine and Serotonin Pathways
Mohammed Ghiboub and others
Inflammatory Bowel Diseases, Volume 29, Issue 5, May 2023, Pages 684–694, https://doi.org/10.1093/ibd/izac262
Clinical Research
Trends in Medical Management of Moderately to Severely Active Ulcerative Colitis: A Nationwide Retrospective Analysis
William Yuan and others
Inflammatory Bowel Diseases, Volume 29, Issue 5, May 2023, Pages 695–704, https://doi.org/10.1093/ibd/izac134
A Systematic Review of Crohn’s Disease Case Definitions in Administrative or Claims Databases
Susan Hutfless and others
Inflammatory Bowel Diseases, Volume 29, Issue 5, May 2023, Pages 705–715, https://doi.org/10.1093/ibd/izac131
The Performance of the Rutgeerts Score, SES-CD, and MM-SES-CD for Prediction of Postoperative Clinical Recurrence in Crohn’s Disease
Neeraj Narula and others
Inflammatory Bowel Diseases, Volume 29, Issue 5, May 2023, Pages 716–725, https://doi.org/10.1093/ibd/izac130
Primary Care Professionals’ Attitudes Towards Vaccination Recommendation for Patients With Inflammatory Bowel Disease
Fang Xu and others
Inflammatory Bowel Diseases, Volume 29, Issue 5, May 2023, Pages 726–734, https://doi.org/10.1093/ibd/izac129
Utilization of Colonoscopy Following Treatment Initiation in U.S. Commercially Insured Patients With Inflammatory Bowel Disease, 2013-2019
Jeff Y Yang and others
Inflammatory Bowel Diseases, Volume 29, Issue 5, May 2023, Pages 735–743, https://doi.org/10.1093/ibd/izac136
Clostridium difficile Infection in Patients with Ulcerative Colitis Treated with Tofacitinib in the Ulcerative Colitis Program
Edward V Loftus and others
Inflammatory Bowel Diseases, Volume 29, Issue 5, May 2023, Pages 744–751, https://doi.org/10.1093/ibd/izac139
Indirect Costs of Inflammatory Bowel Diseases: A Comparison of Patient-Reported Outcomes Across 12 European Countries
Przemysław Holko and others
Inflammatory Bowel Diseases, Volume 29, Issue 5, May 2023, Pages 752–762, https://doi.org/10.1093/ibd/izac144
Examination Under Anesthesia May Not Be Universally Required Prior to Anti-TNF Therapy in Perianal Crohn’s Disease: A Comparative Cohort Study
Melissa Chan and others
Inflammatory Bowel Diseases, Volume 29, Issue 5, May 2023, Pages 763–770, https://doi.org/10.1093/ibd/izac143
Basic Science Research
The Clinical Response of Upadacitinib and Risankizumab Is Associated With Reduced Inflammatory Bowel Disease Anti-TNF-α Inadequate Response Mechanisms
Jing Wang and others
Inflammatory Bowel Diseases, Volume 29, Issue 5, May 2023, Pages 771–782, https://doi.org/10.1093/ibd/izac246
Histones of Neutrophil Extracellular Traps Directly Disrupt the Permeability and Integrity of the Intestinal Epithelial Barrier
Hsuan-Ju Lai and others
Inflammatory Bowel Diseases, Volume 29, Issue 5, May 2023, Pages 783–797, https://doi.org/10.1093/ibd/izac256
Epicutaneous Immunotherapy with CBir1 Alleviates Intestinal Inflammation
Xin Chen and others
Inflammatory Bowel Diseases, Volume 29, Issue 5, May 2023, Pages 798–807, https://doi.org/10.1093/ibd/izac261
Clinical Review
Efficacy of Fecal Microbiota Transplantation in the Treatment of Active Ulcerative Colitis: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials
Nabil El Hage Chehade and others
Inflammatory Bowel Diseases, Volume 29, Issue 5, May 2023, Pages 808–817, https://doi.org/10.1093/ibd/izac135
Basic Science Review
The Pathogenicity and Synergistic Action of Th1 and Th17 Cells in Inflammatory Bowel Diseases
Hui Cao and others
Inflammatory Bowel Diseases, Volume 29, Issue 5, May 2023, Pages 818–829, https://doi.org/10.1093/ibd/izac199
Brief Report - Clinical
Long-Term Outcomes After Ustekinumab Dose Intensification for Inflammatory Bowel Diseases
Rahul S Dalal and others
Inflammatory Bowel Diseases, Volume 29, Issue 5, May 2023, Pages 830–833, https://doi.org/10.1093/ibd/izac164
IBD Flare in the COVID-19 Pandemic: Therapy Discontinuation Is to Blame
Cristina Bezzio and others
Inflammatory Bowel Diseases, Volume 29, Issue 5, May 2023, Pages 834–836, https://doi.org/10.1093/ibd/izac173
Case Report
Oral Vancomycin Induced and Maintained Clinical and Endoscopic Remission in Ulcerative Colitis and Primary Sclerosing Cholangitis Post-liver Transplantation
Hisham S Almomen and Badr Al-Bawardy
Inflammatory Bowel Diseases, Volume 29, Issue 5, May 2023, Pages 837–838, https://doi.org/10.1093/ibd/izad040
Invited Editorial
Editorial: Hospitalization Experiences and Post-traumatic Stress in Inflammatory Bowel Disease: Opportunities for Change
Heidi Glynn and others
Inflammatory Bowel Diseases, Volume 29, Issue 5, May 2023, Pages 839–841, https://doi.org/10.1093/ibd/izac166
Letters to the Editor
Plant-Based Diet Recommended for Inflammatory Bowel Disease
Mitsuro Chiba and others
Inflammatory Bowel Diseases, Volume 29, Issue 5, May 2023, Pages e17–e18, https://doi.org/10.1093/ibd/izac279
Reply: Plant-Based Diet Recommended for Inflammatory Bowel Disease
Berkeley N Limketkai
Inflammatory Bowel Diseases, Volume 29, Issue 5, May 2023, Page e19, https://doi.org/10.1093/ibd/izad022
Advertisement
Advertisement